Insulin-like growth factor 2
| GO Term | Evidence Code | Reference |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| ossification |
|
|
| in utero embryonic development | ||
| embryonic placenta development | ||
| glucose metabolic process |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| insulin-like growth factor receptor binding | ||
| integrin binding | ||
| hormone activity | ||
| growth factor activity | ||
| growth factor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 163 |
|
|
| Pathway Name | Organism |
|---|---|
| IRS-related events triggered by IGF1R | Sus scrofa |
| Platelet degranulation | Sus scrofa |
| Regulation of IGF Activity by IGFBP | Sus scrofa |
| SHC-related events triggered by IGF1R | Sus scrofa |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | Sus scrofa |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026